Ocata Therapeutics Inc fka OCAT

[rumper]

LOL What?Huh?_30Days_Later WE_WILL_KNOW

one month[30 Days] after treatment, his vision had improved 10 lines, which is 20/40

This is why I think phase 2 isn't going to take very long.
Sure they'll keep watching the patients, but
they will be watching people with fresh healthy eyes.

"We treated a 75-year-old horse rancher whose vision was 20/400, which is legally blind, and one month[30 Days] after treatment, his vision had improved 10 lines, which is 20/40 -- and he can even ride his horses again. Other patients report similarly dramatic improvements. It's made a huge difference in the quality of their life," Lanza added


Phase 2---Patient 1, One Month, 30 Days! RESULTS! or a good indication!
Phase 2---Patient 1, One Month, 30 Days! RESULTS! or a good indication!
Phase 2---Patient 1, One Month, 30 Days! RESULTS! or a good indication!



If Ocata injects all 20 within a week or Two,
this will drive the market to frenzy,
absolute frenzy!!!

Let us break down the above paragraph:

We treated a 75-year-old horse rancher whose vision was 20/400...
and one month after...
his vision was 20/40

Other patients report similarly dramatic improvements.
(other---means more than only cowboy)


Ocata is ONE eyeball injection.
Eylea is eyeball injections for LIFE!!!


Cowboy 20/40 is REAL !

The RPE Therapy is REAL !

The hard science is DONE.

The only obstacle left is the FDA.
And they're ONBOARD !

ONE INJECTION, ONE, and we are officially in FDA phase 2 trials.
And 30 days later we will know.

Phase 2 will tell us if the 75 year old rancher was a lucky one shot,
or if the RPE therapy works for everyone with a repairable retina.
We'll see.
I think the evidence already warrants optimism,
if not exuberance.

From the CC 12Mar2015
PW_CC_12mar15(edited)
Our number one corporate objective for 2015 is the initiation of the next phase of our clinical trials.

We plan to initiate our Phase II trial for dry AMD in the second quarter of this[2015] year.

This Phase II study will include up to three cohorts of approximately 20 patients each.

We intend to complete the first cohort dosing during 2015.

Each of the three cohorts will be treated with a different immune suppression regimen to determine how much, if any, immune suppression is required.
PW_CC_12mar15(end)

I bet they'll find ONE patient to inject in Q2, and get the ball rolling.

Find a 20/80 guy, and BAM!,
a month later he's 20/20, BAM !

That's all it would take to light this candle.

Let's Light This Candle !


http://www.sciencetimes.com/articles/812/20141016/stem-cell-technology-macular-degeneration-visual-problems.htm

Stem Cells provide long-term treatment for the almost blind

Alfer A. Guiang Oct 16, 2014 09:32 AM EDT

In recent years, the wonder of stem cells has been subject of discussions in the academe and the medical world with the discovery on stem cells' efficacy in certain illnesses, including the recent findings on type 1 Diabetes.

Earlier this week, another breakthrough discovery circulated in most media venues, and this still involves stem cell transplants for the treatment of forms of macular degeneration which is said to be a leading cause of loss of vision.

The study was funded by U.S.-based company called Advanced Cell Technology[now Ocata] and was published on The Lancet on October 15 (Wednesday).

The research involved 18[now 38] people who received the transplants to treat forms of severe vision loss resulting from two types of macular degeneration.